Dan Pollyea, MD, MS, associate professor, clinical director of leukemia services, University of Colorado Denver – Anschutz Medical Campus, discusses the current role of maintenance therapy in patients with acute myeloid leukemia (AML) who are unfit for intensive chemotherapy.
CU Anschutz
Fitzsimons Building
13001 East 17th Place
Aurora, CO 80045